DCM
PFE icon

Dudley Capital Management’s Pfizer PFE Stock Holding History

Dudley Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,000
Closed -$97K – 140
2025
Q2 		$97K Buy
+4,000
New +$93.3K 0.05% 125

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Dudley Capital Management's PFE Position: Q2 2026 in Review

Dudley Capital Management increased its Pfizer (PFE) stake by 0.05% in Q2 2026, buying an estimated $942 and bringing the position to 68,090 shares worth $1.64M. The position accounts for 0.66% of the portfolio, ranked #39.

Dudley Capital Management first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.77M in Q4 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Dudley Capital Management held 68,090 shares of Pfizer worth $1.64M as of Q2 2026.
  • Dudley Capital Management bought 36 Pfizer shares in Q2 2026, an estimated $942.
  • Pfizer made up 0.66% of Dudley Capital Management's portfolio in Q2 2026, its #39 holding.
  • Dudley Capital Management first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Dudley Capital Management's Pfizer position peaked at $3.77M in Q4 2022.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Dudley Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.